Plasma cathelicidin and longitudinal lung function in current and former smokers.
Robert M BurkesJacquie AstemborskiAllison A LambertTodd T BrownRobert A WiseGregory D KirkM Bradley DrummondPublished in: PloS one (2019)
In current and former smokers with preserved lung function, low cathelicidin is associated with sustained lung function reductions at six and 18 months, suggesting that cathelicidin may be an informative biomarker to predict persistent lung function disparities among at-risk individuals.